Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease
Open Access
- 28 December 2012
- journal article
- review article
- Published by Springer Nature in Comparative Hepatology
- Vol. 11 (1) , 1-5
Abstract
Alcoholic liver disease (ALD) is a significant cause of death and morbidity. Detection of liver fibrosis at an early stage could provide opportunities for more optimal management. Serum markers of liver fibrosis offer an alternative to biopsy. Evidence of the performance of biomarkers in ALD is needed and a systematic review to evaluate available studies was conducted.Keywords
This publication has 41 references indexed in Scilit:
- Systematic review: non‐invasive methods of fibrosis analysis in chronic hepatitis CAlimentary Pharmacology & Therapeutics, 2009
- Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease†Hepatology, 2008
- Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non‐invasive laboratory testsAlimentary Pharmacology & Therapeutics, 2008
- Meta-analyses of FibroTest diagnostic value in chronic liver diseaseBMC Gastroenterology, 2007
- Worldwide mortality from cirrhosis: An update to 2002Journal of Hepatology, 2007
- Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver diseaseGut, 2006
- Performance of serum marker panels for liver fibrosis in chronic hepatitis CJournal of Hepatology, 2006
- Liver cirrhosis mortality rates in Britain, 1950 to 2002The Lancet, 2006
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003
- Serum hyaluronate correlates with histological progression in alcoholic liver diseaseEuropean Journal of Gastroenterology & Hepatology, 2003